130
Views
3
CrossRef citations to date
0
Altmetric
Correspondence

Inflammatory and immune-related conditions associated with Waldenström macroglobulinemia: a single center experience

, , , &
Pages 1179-1180 | Received 26 May 2014, Accepted 03 Jul 2014, Published online: 20 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stephen M. Ansell. (2015) Waldenström macroglobulinemia and autoimmunity: what's the connection?. Leukemia & Lymphoma 56:4, pages 845-846.
Read now

Articles from other publishers (2)

Vaibhav Kumar, Nathan D. Montgomery, Hendrik W. van Deventer & Young E. Whang. (2023) Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report. Journal of Medical Case Reports 17:1.
Crossref
Tomasz Sewastianik, Maria Luisa GuerreraKeith AdlerPeter S. DennisKyle WrightVignesh ShanmugamYing HuangHelen TantonMeng Jiang, Amanda KofidesMaria G. DemosAudrey Dalgarno, Neil A. Patel, Anwesha Nag, Geraldine S. PinkusGuang Yang, Zachary R. Hunter, Petr JarolimNikhil C. Munshi, Steven P. TreonRuben D. Carrasco. (2019) Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells. Blood Advances 3:21, pages 3360-3374.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.